RP

Rehana Parvin

Director Director DIN 09235469
DIN 09235469 First appointment Jul 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2021
Shareholding value Locked Premium profile

About Rehana Parvin

Data last updated:

Rehana Parvin has 5 years in corporate governance. Formerly with 1 company, such as Inzet Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09235469
Primary Designation Director
First Appointment 12 Jul 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Inzet Pharmaceutical Private Limited U24110WB2021PTC246326
Director12 Jul 20212021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Inzet Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Rehana Parvin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rehana Parvin

Rehana Parvin has 5 years in corporate governance. Formerly with 1 company, such as Inzet Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Rehana Parvin is associated with 0 companies as a director.

Rehana Parvin has expertise in General Business.

Rehana Parvin has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available